Fundz

Dantari Debuts With $47 Million Series A To Advance Best-In-Class Targeted Medicines For Solid Tumors

PRIVATEDec 08, 2022

Amount Raised

$47 Million

Round Type

Series A

Thousand OaksBiotechnologyTherapeutics

Investors

Alexandria Venture InvestmentsCorner VenturesWestlake Village Bio Partners

Description

Dantari, Inc. ("Dantari"), a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers and other diseases, today announced its emergence from stealth mode with $47 million Series A financing. The Series A financing was led by Westlake Village BioPartners ("Westlake") and included participation from Corner Ventures, Alexandria Venture Investments, and Caltech. The Company also announced the appointment of Richard A

Quick answer

Dantari raised $47 Million in a Series A round, dated December 8, 2022. Investors: Alexandria Venture Investments, Corner Ventures and Westlake Village Bio Partners. Dantari is based in Thousand Oaks, California, United States.

How much did Dantari raise?
Dantari raised $47 Million in a Series A round on December 8, 2022.
Who invested in Dantari?
Alexandria Venture Investments, Corner Ventures and Westlake Village Bio Partners are named as investors in this round.
What does Dantari do?
Dantari, Inc. is a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers and other diseases.
Where is Dantari based and how big is it?
Dantari is based in Thousand Oaks, California, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Dantari that raised within 45 days of this round, from Fundz verified event records.

  • ADARx Pharmaceuticals, Inc. raised $46M (Funding Round) on January 20, 2023.
  • Repare Therapeutics raised $1.5M (Seed) on January 19, 2023.
  • Diamante Srl raised an undisclosed amount (Seed) on January 17, 2023.
  • MPC Therapeutics raised an undisclosed amount (Seed) on January 11, 2023.
  • Inotrem raised an undisclosed amount (Funding Round) on January 9, 2023.
  • Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.

Who to call at Dantari, and when

A new round usually means Dantari is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Dantari raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dantari, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dantari. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dantari

Location

Thousand Oaks, California, United States

About

Dantari, Inc. is a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers and other diseases. Dantari is advancing a pipeline of T-HDC (Targeted High-capacity Drug Conjugate) chemotherapeutic agents starting with DAN-222 and next-generation ADC therapeutics T-HDC technology originating from Caltech. Dantari's HDC and T-HDC platform technology uses chemically defined polymers with a high drug-antibody ratio (DAR), and a high degree of control and flexibility to optimize performance of targeted drug conjugates that can leverage validated targets across a broad range of therapeutic payload options. Visit us at www.dantari.com to learn more.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dantari raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Dantari's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Dantari raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.